Thrivent Financial for Lutherans Trims Position in Azenta, Inc. (NASDAQ:AZTA)

Thrivent Financial for Lutherans cut its position in shares of Azenta, Inc. (NASDAQ:AZTA) by 11.8% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,492 shares of the company’s stock after selling 1,536 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Azenta were worth $557,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in AZTA. Hantz Financial Services Inc. bought a new stake in shares of Azenta during the second quarter valued at approximately $30,000. Farther Finance Advisors LLC boosted its position in shares of Azenta by 20.0% during the third quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock valued at $74,000 after purchasing an additional 256 shares in the last quarter. Benjamin F. Edwards & Company Inc. boosted its position in shares of Azenta by 150.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company’s stock valued at $84,000 after purchasing an additional 955 shares in the last quarter. Net Worth Advisory Group bought a new stake in shares of Azenta during the third quarter valued at approximately $205,000. Finally, Aigen Investment Management LP bought a new stake in shares of Azenta during the third quarter valued at approximately $214,000. 99.08% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CFO Herman Cueto sold 1,595 shares of the company’s stock in a transaction on Thursday, October 17th. The stock was sold at an average price of $43.68, for a total transaction of $69,669.60. Following the transaction, the chief financial officer now directly owns 24,604 shares of the company’s stock, valued at $1,074,702.72. This represents a 6.09 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director William L. Cornog purchased 12,500 shares of the stock in a transaction dated Monday, November 18th. The shares were acquired at an average cost of $39.60 per share, for a total transaction of $495,000.00. Following the completion of the acquisition, the director now owns 14,755 shares of the company’s stock, valued at approximately $584,298. This represents a 554.32 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have sold a total of 3,018 shares of company stock valued at $126,689 over the last ninety days. 1.77% of the stock is currently owned by corporate insiders.

Azenta Trading Down 0.1 %

Azenta stock opened at $46.93 on Thursday. The business’s fifty day simple moving average is $44.87 and its two-hundred day simple moving average is $49.81. Azenta, Inc. has a 12 month low of $38.82 and a 12 month high of $69.16. The company has a market capitalization of $2.14 billion, a price-to-earnings ratio of -15.80 and a beta of 1.49.

Azenta (NASDAQ:AZTA) last released its earnings results on Tuesday, November 12th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.10 by $0.08. The business had revenue of $170.00 million for the quarter, compared to the consensus estimate of $169.66 million. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. The company’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.13 earnings per share. On average, equities research analysts predict that Azenta, Inc. will post 0.4 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Needham & Company LLC dropped their price target on Azenta from $69.00 to $55.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Evercore ISI dropped their target price on Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a report on Tuesday, October 1st. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, Azenta has a consensus rating of “Hold” and an average target price of $63.60.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.